Peter Devine
Chief Executive Officer
Healthcare Management
UNISEED
Australia
Biography
Peter Devine is CEO of Uniseed and has has extensive experience at board and executive management levels in the commercialisation of early stage technologies, having held senior R&D, business development and commercialisation positions in a number of Australian companies and Australian universities. Recent successes include Fibrotech Therapeutics'​ sale to Shire in 2014; the Spinifex Pharmaceuticals sale to Novartis in 2015; and the Hatchtech sale to Dr Reddy's in 2015, where Peter had served as a Board member on these companies.
Research Interest
Business Development ,Business Strategy ,Biotechnology ,Business Planning ,Executive Management
